Literature DB >> 27281530

Anti-NMDA receptor antibody encephalitis and neuroendocrine pancreatic tumor: Causal link?

Vadim Afanasiev1, Marie-Laure Brechemier1, William Boisseau1, Romain Ducoudray1, Marie-Eve Mayeur1, David Meyronet1, Anne Peskine1, Virginie Desestret1, Dimitri Psimaras2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27281530      PMCID： PMC4932238          DOI： 10.1212/WNL.0000000000002809

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 2.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

3.  Anti-N-methyl-D-aspartate receptor encephalitis associated with carcinosarcoma with neuroendocrine differentiation of the uterus.

Authors:  Makoto Hara; Akihiko Morita; Satoshi Kamei; Mai Yamaguchi; Taku Homma; Norimichi Nemoto; Kenji Sugita; Tatsuo Yamamoto; Josep Dalmau
Journal:  J Neurol       Date:  2011-02-03       Impact factor: 4.849

4.  Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

Authors:  M J Titulaer; R Soffietti; J Dalmau; N E Gilhus; B Giometto; F Graus; W Grisold; J Honnorat; P A E Sillevis Smitt; R Tanasescu; C A Vedeler; R Voltz; J J G M Verschuuren
Journal:  Eur J Neurol       Date:  2010-09-29       Impact factor: 6.089

5.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182
  5 in total
  5 in total

1.  Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Authors:  Chloé Bost; Eve Chanson; Géraldine Picard; David Meyronet; Marie-Eve Mayeur; François Ducray; Veronique Rogemond; Dimitri Psimaras; Jean-Christophe Antoine; Jean-Yves Delattre; Virginie Desestret; Jerome Honnorat
Journal:  J Neurol       Date:  2018-07-12       Impact factor: 4.849

Review 2.  Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.

Authors:  Cai-Yun Liu; Jie Zhu; Xiang-Yu Zheng; Chi Ma; Xu Wang
Journal:  Mediators Inflamm       Date:  2017-06-18       Impact factor: 4.711

3.  Phylogenetic Analysis to Explore the Association Between Anti-NMDA Receptor Encephalitis and Tumors Based on microRNA Biomarkers.

Authors:  Hsiuying Wang
Journal:  Biomolecules       Date:  2019-10-05

4.  An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits.

Authors:  Yuya Kobayashi; Mitsuto Sato; Michiaki Kinoshita; Masaki Kakizawa; Kayoko Higuchi; Mitsunori Yamada; Minori Kodaira; Yoshiki Sekijima
Journal:  Intern Med       Date:  2020-06-02       Impact factor: 1.271

5.  COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA.

Authors:  Hsiuying Wang
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.